CORCEPT THERAPEUTICS INC (CORT) Total liabilities 2016–2025
CORCEPT THERAPEUTICS INC (CORT) total liabilities at each fiscal year-end, per SEC filings.
$188.8MFY2025 · since FY2016: $27.4M → $188.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $188.8M | +17.3% |
| FY2024 | $161.0M | +40.2% |
| FY2023 | $114.8M | +40.7% |
| FY2022 | $81.6M | +70.2% |
| FY2021 | $48.0M | -0.9% |
| FY2020 | $48.4M | +17.7% |
| FY2019 | $41.1M | +14.8% |
| FY2018 | $35.8M | +21.1% |
| FY2017 | $29.6M | +8.0% |
| FY2016 | $27.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CORT financial trends
CORT RevenueCORT Net incomeCORT Net marginCORT Gross profitCORT Gross marginCORT Operating incomeCORT Operating marginCORT Operating cash flowCORT Free cash flowCORT Capital expendituresCORT Return on equityCORT Stock buybacksCORT Dividends paidCORT Total assetsCORT Shareholders’ equityCORT overview →